Acutus Medical, Inc.
AFIBDelisted May 16, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001522860
Acutus Medical, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Jan 28, 2025; 23 institutions reported holding it in 13F filings for Q1 2024, worth $1.24M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Acutus Medical, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AFIB is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 1
- −22 vs. Q1 2024
- Shares held
- 6.40K
- −6.59M (−99.9%) vs. Q1 2024
- Total value
- $227
- −$1.24M (−100.0%) vs. Q1 2024
- New holders
- 0
- 0 more added
- Sold out
- 22
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AFIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $4 |
| Q1 2025 | 1 | $85 |
| Q4 2024 | 1 | $165 |
| Q3 2024 | 1 | $252 |
| Q2 2024 | 1 | $227 |
| Q1 2024 | 23 | $1.24M |
| Q4 2023 | 29 | $1.41M |
| Q3 2023 | 30 | $5.98M |
| Q2 2023 | 35 | $8.13M |
| Q1 2023 | 38 | $6.96M |
| Q4 2022 | 38 | $10.6M |
| Q3 2022 | 37 | $9.09M |
| Q2 2022 | 47 | $12.5M |
| Q1 2022 | 65 | $22.3M |
| Q4 2021 | 71 | $60.7M |
| Q3 2021 | 70 | $179.1M |
| Q2 2021 | 64 | $393.9M |
| Q1 2021 | 67 | $304.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Acutus Medical, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| S.A. Mason LLC | 6,400 | $227 | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,660,808−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,648,386−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −347,800−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −278,220−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −206,624−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −206,681−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −78,504−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −51,871−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −35,038−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −17,541−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −11,869−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,038−100.0% | Sold out |
| Voisard Asset Management Group, Inc. | 0 | $0 | 0.00% | −8,700−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −6,238−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −5,625−100.0% | Sold out |
| Westside Investment Management, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,229−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −301−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |